Skip to main content

Table 2 Features of the primary tumours regarding primary treatment regimen, follow up time and cause of death

From: Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study

Tumour Age Disease site Stage TP53 gene status Surgery Radiation- therapy (radical) Disease free in months Overall survival in months Death related to HNSCC
1 65 larynx 2 wild type Yes Yes 166 166 No
2 61 larynx 3 wild type Yes Yes 145 145 No
3 56 pharynx 3 mutation outside L2/L3/LSH motif Yes Yes 156 156 No
4 65 larynx 3 mutation outside L2/L3/LSH motif Yes Yes 121 121 No
5 48 pharynx 3 wild type Yes Yes   74 Yes
7 48 oral cavity 3 wild type Yes Yes 158 158 No
8 75 oral cavity 2 wild type Yes Yes 6 15 Yes
9 28 oral cavity 3 mutation outside L2/L3/LSH motif Yes Yes 155 155 No
10 58 oral cavity 3 wild type Yes Yes 11 8 Yes
12 78 oral cavity 2 mutation in L2/L3/LSH motif Yes No 7 40 Yes
13 83 larynx 2 wild-type Yes Yes 51 51 No
14 45 larynx 1 wild type Yes Yes 122 122 No
16 85 pharynx 3 mutation in L2/L3/LSH motif Yes Yes 32 32 No
17 74 oral cavity 3 wild type Yes No 3 12 Yes
18 72 larynx 1 mutation outside L2/L3/LSH motif Yes Yes 164 164 No
19 57 larynx 4 mutation outside L2/L3/LSH motif Yes Yes 24 24 No
20 62 oral cavity 3 mutation in L2/L3/LSH motif No only palliative 0 1 Yes
26 68 larynx 4 wild type Yes Yes 9 18 Yes
28 65 oral cavity 4 mutation in L2/L3/LSH motif No only palliative 6 22 Yes
29 33 oral cavity 3 mutation outside L2/L3/LSH motif Yes Yes 157 157 No
31 71 oral cavity 1 mutation in L2/L3/LSH motif Yes No 20 84 Yes
32 39 oral cavity 3 mutation in L2/L3/LSH motif Yes Yes 37 40 Yes
39 68 larynx 4 wild type p53 Yes Yes 11 19 Yes
41 53 nose 2 wild type p53 Yes Yes 7 18 Yes
43 74 larynx 2 mutation in L2/L3/LSH motif No Yes 154 154 No
45 70 pharynx 3 wild type p53 Yes Yes 142 142 No
46 62 larynx 1 mutation outside L2/L3/LSH motif Yes Yes 135 135 No
49 62 oral cavity 1 mutation in SSCP Yes No 60 67 Yes
50 49 larynx 3 wild type p53 Yes Yes 122 122 No
51 63 larynx 2 mutation outside L2/L3/LSH motif Yes Yes 109 109 No
52 63 larynx 4 wild type p53 Yes Yes 20 30 Yes
53 74 oral cavity 4 mutation in L2/L3/LSH motif Yes No 35 37 Yes
54 42 larynx 3 mutation outside L2/L3/LSH motif Yes Yes 144 144 No
55 71 larynx 1 wild type p53 Yes Yes 145 145 No
56 59 larynx 4 mutation in L2/L3/LSH motif Yes Yes 155 155 Yes
58 74 pharynx 4 mutation outside L2/L3/LSH motif No Yes 29 32 Yes
59 56 oral cavity 3 wild type p53 Yes Yes 163 163 No
60 69 larynx 4 mutation in L2/L3/LSH motif Yes Yes 22 22 No
61 63 larynx 3 mutation in L2/L3/LSH motif No Yes 15 15 No
62 74 larynx 2 wild type p53 Yes Yes 25 25 No
63 69 larynx 3 mutation in L2/L3/LSH motif Yes No 5 7 Yes
64 56 larynx 3 mutation in L2/L3/LSH motif Yes Yes 151 151 No
65 75 larynx 3 wild type p53 Yes Yes 20 25 Yes
68 76 pharynx 4 SSCP positivity No only palliative 0 4 Yes
69 65 larynx 2 mutation outside L2/L3/LSH motif No Yes 12 43 Yes
70 68 sinonasal 4 wild type p53 Yes Yes 160 160 No
Back to article page

Head & Neck Oncology

ISSN: 1758-3284